Study shows high and variable prevalence of PBC in the US
The prevalence of primary biliary cholangitis (PBC) in the U.S. may be high and variable between regions, according to a recent study.
The prevalence of primary biliary cholangitis (PBC) in the U.S. may be high and variable between regions, according to a recent study.
Primary biliary cholangitis (PBC) is often associated with other autoimmune diseases, as well as psychiatric disorders and sleep-related conditions.
If you need a liver transplant due to PBC, here is what you need to know about eligibility, the transplant procedure and post-surgery care.
Itching of the skin (pruritus) is one of the most common symptoms of primary biliary cholangitis (PBC), reported in 60%-70% of people with PBC.
While women with primary biliary cholangitis (PBC) can experience successful pregnancies and have healthy babies, complications may still occur.
We’ve provided the answers to some of the most frequently asked questions related to PBC.
Though there is no known cure for primary biliary cholangitis (PBC), several therapeutic options are available.
There is currently no cure for primary biliary cholangitis (PBC), but there are some options available for patients to delay progression.
The prognosis of primary biliary cholangitis (PBC) varies by patient, but the average time it takes for PBC to progress to the terminal stage is around 15 to 20 years.
The signs and symptoms of primary biliary cholangitis (PBC) vary and may not always correlate with the severity of the damage to the liver.